BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/18/2021 9:35:02 AM | Browse: 601 | Download: 1097
 |
Received |
|
2021-03-14 23:42 |
|
Peer-Review Started |
|
2021-03-15 00:52 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-06-05 01:44 |
|
Revised |
|
2021-06-15 21:58 |
|
Second Decision |
|
2021-08-26 03:28 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-08-27 09:42 |
|
Articles in Press |
|
2021-08-27 09:42 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-09-17 03:58 |
|
Publish the Manuscript Online |
|
2021-09-18 09:35 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Medicine, Research & Experimental |
| Manuscript Type |
Minireviews |
| Article Title |
Mesenchymal stem cells and COVID-19: What they do and what they can do
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ejlal Abu-El-Rub, Ramada R Khasawneh, Fatimah Almahasneh, Zaid Altaany, Nesreen Bataineh, Hana Zegallai and Saravanan Sekaran |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Ejlal Abu-El-Rub, PharmD, PhD, Assistant Professor, Department of Physiology and Pathophysiology, Yarmouk University, Shafiq Irshidat st, Irbid 21163, Jordan. ejlal.abuelrub@yu.edu.jo |
| Key Words |
SARS-CoV-2; COVID-19; Mesenchymal stem cells; Inflammation; Acute respiratory distress syndrome; Pulmonary fibrosis; Pneumonia; Renal injury; Cardiovascular diseases; Regeneration; Anti-inflammatory |
| Core Tip |
Coronavirus disease 2019 (COVID-19) pandemic continues its rampant spread as more vengeant strains emerged in many countries. Severe cases of COVID-19 have been complicated by respiratory failure and multiple organ dysfunction with high mortality rate. Mesenchymal stem cells regenerative and anti-inflammatory abilities can be an innovative approach in repairing the damaged organs and improve the survival rate for critically ill COVID-19 patients. |
| Publish Date |
2021-09-18 09:35 |
| Citation |
Abu-El-Rub E, Khasawneh RR, Almahasneh F, Altaany Z, Bataineh N, Zegallai H, Sekaran S. Mesenchymal stem cells and COVID-19: What they do and what they can do. World J Stem Cells 2021; 13(9): 1318-1337 |
| URL |
https://www.wjgnet.com/1948-0210/full/v13/i9/1318.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v13.i9.1318 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
